Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Immatics Biotechnologies

Immatics Biotechnologies

Immatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.

OverviewStructured DataIssuesContributorsActivity
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Immatics Initiates Second Phase I Clinical Trial of its Unique ACTengine® Platform in Patients with Advanced Solid Cancers

Immatics

https://immatics.com/press-release/immatics-initiates-second-phase-i-clinical-trial-of-its-unique-actengine-platform-in-patients-with-advanced-solid-cancers.html

Web

References

Find more companies like Immatics Biotechnologies

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo